Northup P G, Pruett T L, Stukenborg G J, Berg C L
Division of Gastroenterology and Hepatology, University of Virginia Health System, Virginia, USA.
Am J Transplant. 2006 Oct;6(10):2455-62. doi: 10.1111/j.1600-6143.2006.01501.x. Epub 2006 Aug 21.
It has been demonstrated that low-volume orthotopic liver transplant centers have poorer outcomes compared to high-volume centers. In light of the recent significant changes in liver transplantation, we performed an analysis of transplant center procedure volume and mortality with data from the Model for End-stage Liver Disease (MELD) era. We analyzed 9909 adult liver transplants performed in the United States since the beginning of the MELD allocation system. Transplant centers were categorized by volume of transplants performed per year. Multivariate survival models were constructed with raw survival as the primary endpoint for both high- and low-volume centers. Thirty percent of centers were categorized as low volume (< or =20 liver transplants per year) and 8.2% of all transplants were performed at low-volume centers. The unadjusted raw mortality rate at 1-year post-transplant at high-volume centers (9.5%, 95% CI 9.4-9.5) was significantly lower than the rate at low-volume centers (10.9%, 95% CI 10.4-11.4), p < 0.001. However, after adjusting for disease severity and multiple donor and recipient factors, transplant center volume was no longer a significant predictor of post-transplant survival (HR 0.99, 95% CI 0.99-1.00, p = 0.22). We conclude that transplant center case volume is no longer a significant predictor of post-transplant survival in the MELD era and factors which are currently unaccounted for in present survival models should be investigated.
已证明,与高容量中心相比,低容量原位肝移植中心的治疗效果较差。鉴于近期肝移植领域发生的重大变化,我们利用终末期肝病模型(MELD)时代的数据,对移植中心的手术量和死亡率进行了分析。我们分析了自MELD分配系统启用以来在美国进行的9909例成人肝移植手术。移植中心按每年进行的移植手术量进行分类。以原始生存率作为高容量和低容量中心的主要终点,构建多变量生存模型。30%的中心被归类为低容量中心(每年≤20例肝移植),所有移植手术中有8.2%在低容量中心进行。高容量中心移植后1年的未调整原始死亡率(9.5%,95%可信区间9.4 - 9.5)显著低于低容量中心(10.9%,95%可信区间10.4 - 11.4),p<0.001。然而,在对疾病严重程度以及多个供体和受体因素进行调整后,移植中心的手术量不再是移植后生存的显著预测因素(风险比0.99,95%可信区间0.99 - 1.00,p = 0.22)。我们得出结论,在MELD时代,移植中心的病例数量不再是移植后生存的显著预测因素,应研究当前生存模型中未考虑的因素。